임소윤 (서울아산병원)님 | 한빛사연구자 > 한빛사

서울아산병원

CV File

감염의학

최종업데이트 2026.03.09.

Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 : A Randomized Clinical Trial
- Ann. Intern. Med., Mar 03 2026, | https://doi.org/10.7326/ANNALS-25-04883
- 2026-03
- 의약학
- 한빛사논문
Letter to the Editor with # CTM2-2023-10-2488 entitled 'Antibody responses as correlates of protection against SARS-CoV-2 in the Omicron era: A 5-month prospective cohort study in Korean healthcare workers'
- Clin. Transl. Med., Jan 2024, 14 (1) | https://doi.org/10.1002/ctm2.1551
- 2024-01
- 의약학
- 한빛사논문
Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19
- Clin. Immunol., Available online 27 April 2023, 109628 | https://doi.org/10.1016/j.clim.2023.109628
- 2023-04
- 의약학
- 한빛사논문
Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination
- Clin. Infect. Dis., 2022 Dec 19;75(12):2243-2246 | https://doi.org/10.1093/cid/ciac435
- 2022-12
- 의약학
- 한빛사논문
Clinical and Virological Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta) Variant: A Prospective Cohort Study
- Clin. Infect. Dis., Volume 75, Issue 1, 1 July 2022, Pages e27–e34 | https://doi.org/10.1093/cid/ciac239
- 2022-07
- 의약학
- 한빛사논문
Breakthrough infections and waning immune responses with ChAdOx1 nCoV-19 or mRNA vaccine in healthcare workers
- Clin. Transl. Med., First published: 22 April 2022 | https://doi.org/10.1002/ctm2.804
- 2022-04
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기